SEI Investments
VOR icon

SEI Investments’s Vor Biopharma VOR Stock Holding History

SEI Investments’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$245K Buy
+13,716
New +$193K ﹤0.01% 2895
2024
Q3 		– Sell
-880
Closed -$17.6K – 2773
2024
Q2 		$17.6K Buy
+880
New +$28.5K ﹤0.01% 2637

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SEI Investments's VOR Position: Q1 2026 in Review

SEI Investments opened a new position in Vor Biopharma (VOR) in Q1 2026: 13,716 shares worth $245K. The stake represents ﹤0.01% of the portfolio and ranks #2895 among its holdings. This is a return to the name: SEI Investments previously reported a position in VOR as recently as Q2 2024.

SEI Investments first reported a position in VOR in Q2 2024 and has held it in 2 quarters since. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • SEI Investments held 13,716 shares of Vor Biopharma worth $245K as of Q1 2026.
  • Vor Biopharma was a new SEI Investments position in Q1 2026.
  • Vor Biopharma made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2895 holding.
  • SEI Investments first reported a position in Vor Biopharma in Q2 2024 and has held it in 2 quarters since.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.